NKAP functions as an oncogene and its expression is induced by CoCl<sub>2</sub> treatment in breast cancer via AKT/mTOR signaling pathway
0301 basic medicine
03 medical and health sciences
breast cancer
NKAP
Cancer Management and Research
hypoxia
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
AKT/mTOR signaling pathway
Original Research
3. Good health
DOI:
10.2147/cmar.s178919
Publication Date:
2018-10-28T18:23:41Z
AUTHORS (5)
ABSTRACT
Purpose: NKAP plays an important role in transcriptional repression, T-cell development, maturation and function acquisition, maintenance survival of hematopoietic stem cells, RNA splicing. In this study, we tried to explore the physiological breast cancer. Methods: We investigated expression cancer patients normal controls its correlation with by searching on GEPIA. knocked down MCF-7 cells RNAi technique studied effect cell proliferation, migration, invasion, apoptosis. And revealed under hypoxic conditions vitro. Results: was differentially expressed tissues is a potential prognostic indicator Subsequently, knockdown significantly inhibited proliferation clonality induced apoptosis through caspase 3-dependent pathway. addition, could strongly inhibit migration invasion cells. affected AKT/mTOR signaling pathway markedly reduced phosphorylation AKT mTOR, as well downstream protein. What's interesting CoCl 2 found induce Downregulation hindered impact including adjusting signaling. Conclusion: functioned oncogene, hypoxia via Keywords: NKAP, cancer, hypoxia,
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....